Breakthrough Weight Management Burner Balm Lip Balm Yields Positive Results In Clinical Trial

LOS ANGELES, May 4 /PRNewswire/ -- Pacific Shore Holdings, Inc., today announced completion of a clinical trial for Burner Balm lip balm. Scientific studies now confirm that this revolutionary product line has the ability to really help individuals with weight management.  The lip balm product line is the first lip balm to be infused with dietary ingredients like Green Tea and Hoodia Gordonii extracts as well as chromium picolinate and caffeine, all of which are known as effective ingredients in dietary supplements.  

According to lead clinical investigator, Dr. David E. Toomey, who has orchestrated a multitude of clinical trials for some of the top pharmaceutical manufacturers in the United States, "The product performed better than anyone expected."

The double blind placebo controlled clinical trials were conducted over a twelve week period on over one hundred patients. Dr. Toomey states, "Over the twelve week period the Burner Balm group lost an average of seven to nine pounds versus the placebo group. Many of the patients commented that meal portions shrank considerably while using the product and most were able to cut out snacking all together."

Dr. Allan Kurtz, the product's lead developer, stated, "I knew while the product was in the prototype stage, that it would yield positive results." According to Dr. Kurtz, the dietary supplement extracts are absorbed into the blood stream through the many blood vessels located in the mucus membrane in our lips. This coupled with a slight continuous ingestion of key dietary supplement extracts, when used as directed, allows all of the dietary ingredients to be absorbed faster and steadier into the bloodstream than ingesting pills or powder supplements. Pills and supplements have to travel to the stomach before they are absorbed. "The use of a lip balm is also far less invasive than ingesting pills and drinking diet potions, which commonly cause side effects such as upset stomachs and nervousness," states Dr. Kurtz.

Industry insiders predict that Pacific Shore Holdings has managed to create a niche for itself in the fast-growing market for cosmeceuticals where it will soon outdistance the competition. "The clinical trial results come as no surprise, as patients and customers from around the world continue ordering," states Matthew Mills, Pacific Shore Holdings, Inc. President and CEO. According to the company, over the last several months, they have been working with multiple biochemists and physicians to continue improving the formula of the product line by increasing the percentage levels of the key dietary extracts.

"We are very pleased with the release of the fourth generation formulation which we feel will yield even better results in the continued patient testing," states Mr. Mills.

1 2 Next › Last »